In current years, FDA has accepted quite a lot of items of software program that use synthetic intelligence (AI) underneath its medical system approval system. FDA accepted solely 5 AI-power medical units in 2015, however accepted 115 of those in 2021 and certain will approve much more in 2022.
Which firms are those with probably the most AI-power medical units that have been granted FDA approval this 12 months (2022) up to now? An attention-grabbing weblog submit by Joel Selanikio finds that enormous trade incumbents are those who’re getting probably the most AI-related medical system approvals this 12 months.
While we do see quite a lot of new firms getting approval, trade incumbents have the benefit of bigger information units and the flexibility to unfold the comparatively mounted price of AI growth throughout extra product varieties. Nevertheless, there are actually alternatives for younger start-ups to get in on the AI healthcare market as nicely.